90 related articles for article (PubMed ID: 6162087)
1. Potentiation and inhibition of interferon action: antiviral and antitumor studies.
Fleishmann WR
Med Pediatr Oncol; 1981; 9(1):89-92. PubMed ID: 6162087
[No Abstract] [Full Text] [Related]
2. Potentiation of interferon action.
Schwarz LA; Fleischmann WR
Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
[TBL] [Abstract][Full Text] [Related]
3. [Interferon as an antiviral, antineoplastic and immunomodulating agent].
Inglot AD
Postepy Hig Med Dosw; 1980; 34(2):89-105. PubMed ID: 6165980
[No Abstract] [Full Text] [Related]
4. [Interferon].
Gresser I
Rev Infirm; 1983 Apr; 33(7):47-53. PubMed ID: 6189174
[No Abstract] [Full Text] [Related]
5. The dream for interferon.
Baron S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1294-300. PubMed ID: 7535725
[No Abstract] [Full Text] [Related]
6. Interferon: mechanisms of action and clinical value.
Houglum JE
Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965
[TBL] [Abstract][Full Text] [Related]
7. Prevention of interferon-induced augmentation of cellular antitumor effector mechanisms by phorbol esters.
Keller R; Aguet M; Tovey M; Stitz L
Cancer Res; 1982 Apr; 42(4):1468-72. PubMed ID: 6174224
[TBL] [Abstract][Full Text] [Related]
8. Prospects in interferon research.
Krim M
Tex Rep Biol Med; 1981-1982; 41():681-92. PubMed ID: 6189231
[No Abstract] [Full Text] [Related]
9. [Mechanisms of the antitumor effects interferons].
Adam Z
Vnitr Lek; 1994 Jan; 40(1):56-8. PubMed ID: 7511261
[TBL] [Abstract][Full Text] [Related]
10. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
Billiau A
J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
[TBL] [Abstract][Full Text] [Related]
11. Interferon as therapeutic agent.
Borecký L; Fuchsberger N
Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
[TBL] [Abstract][Full Text] [Related]
12. Interferon-new wonder drug or old laboratory curiosity?
Tannock GA
Med J Aust; 1981 Oct; 2(7):352-6. PubMed ID: 6170870
[No Abstract] [Full Text] [Related]
13. [The interferon system].
Dianzani F; Dolei A
Ann Ist Super Sanita; 1987; 23(4):765-8. PubMed ID: 2454598
[No Abstract] [Full Text] [Related]
14. [Interferons].
Aymard JP; May T; Canton P; Nettier P; Streiff F
Servir; 1988; 36(4):217-23. PubMed ID: 2462750
[No Abstract] [Full Text] [Related]
15. [Metabolic substances produced by animal cells--interferon].
Kishida T; Oku T
Yakugaku Zasshi; 1983 May; 103(5):483-96. PubMed ID: 6196476
[No Abstract] [Full Text] [Related]
16. [Nuclear pathway of interferons].
Silvennoinen O; Julkunen I; Alitalo K
Duodecim; 1993; 109(17):1447-9. PubMed ID: 7536657
[No Abstract] [Full Text] [Related]
17. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
Fleischmann WR
Cancer Res; 1982 Mar; 42(3):869-75. PubMed ID: 6174218
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced biochemical changes in cell membranes: possible role of cellular enzyme superoxide dismutase.
Pottathil R; Lang DJ
Prog Clin Biol Res; 1983; 135():275-97. PubMed ID: 6198667
[TBL] [Abstract][Full Text] [Related]
19. [The drug of first choice: interferon. Clinical pharmacological principles].
Del Vecchio S; Dianzani F
Minerva Gastroenterol Dietol; 1995 Mar; 41(1):81-7. PubMed ID: 7542487
[No Abstract] [Full Text] [Related]
20. [Interferon in the treatment of viral, neoplastic and immunologic diseases].
Inglot AD
Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
